drugset / Trial / NCT06330168

Paravertebral Calcitonin in Thoracotomy

NCT06330168

Completed 92 enrolled Tanta University
RandomizedParallel-groupTriple-blindPrevention

Summary

This prospective randomized double-blinded controlled study will be conducted to evaluate the effect of adding calcitonin to bupivacaine in thoracic paravertebral block for patients undergoing thoracotomy.

Timeline

Start
2024-03-28
Primary completion
2025-05-14
Completion
2026-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitonin Protein / enzyme biologic 100 iu Other
Background Bupivacaine Other / unclassified 20 ml Other
Background Fentanyl Other / unclassified 100 ug Other

Indications

No indication recorded.